Acadia Healthcare Company Inc (ACHC) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 56.68
(+94.76%)
Based on the Acadia Healthcare Company Inc stock forecast from 8 analysts, the average analyst target price for Acadia Healthcare Company Inc is USD 56.68 over the next 12 months. Acadia Healthcare Company Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Acadia Healthcare Company Inc is Bullish , which is based on 10 positive signals and 4 negative signals. At the last closing, Acadia Healthcare Company Inc’s stock price was USD 29.10. Acadia Healthcare Company Inc’s stock price has changed by -0.38% over the past week, -4.81% over the past month and -61.61% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for Acadia Healthcare Company Inc
No recent average analyst rating found for Acadia Healthcare Company Inc
Company Overview Acadia Healthcare Company Inc
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee. Read Less
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder fa...Read More
Frequently Asked Questions About Acadia Healthcare Company Inc (ACHC) Stock
Based on ratings from 8 analysts Acadia Healthcare Company Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 11 buy, sell and 6 hold ratings.
Unfortunately we do not have enough data on ACHC's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for ACHC is USD 56.68 over the next 12 months. The maximum analyst target price is USD 91 while the minimum anlayst target price is USD 35.
ACHC stock's Price/Earning ratio is 9.85.
Our analysis grades ACHC stock's Price / Earning ratio at B+. This means that ACHC stock's Price/Earning ratio is above 12% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this ACHC may be undervalued for its sector.
The last closing price of ACHC's stock was USD 29.10.
The most recent market capitalization for ACHC is USD 2.54B.
Based on targets from 8 analysts, the average taret price for ACHC is projected at USD 56.68 over the next 12 months.
This means that ACHC's stock price may go up by +94.76% over the next 12 months.
We can't find any ETFs which contains Acadia Healthcare Company Inc's stock.
As per our most recent records Acadia Healthcare Company Inc has 19,192 Employees.
Acadia Healthcare Company Inc's registered address is 6100 Tower Circle, Franklin, TN, United States, 37067.
You can get more information about it from Acadia Healthcare Company Inc's website at https://www.acadiahealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Acadia Healthcare Company Inc (ACHC) Stock
Based on ratings from 8 analysts Acadia Healthcare Company Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 11 buy, sell and 6 hold ratings.
Unfortunately we do not have enough data on ACHC's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for ACHC is USD 56.68 over the next 12 months. The maximum analyst target price is USD 91 while the minimum anlayst target price is USD 35.
ACHC stock's Price/Earning ratio is 9.85.
Our analysis grades ACHC stock's Price / Earning ratio at B+. This means that ACHC stock's Price/Earning ratio is above 12% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this ACHC may be undervalued for its sector.
The last closing price of ACHC's stock was USD 29.10.
The most recent market capitalization for ACHC is USD 2.54B.
Based on targets from 8 analysts, the average taret price for ACHC is projected at USD 56.68 over the next 12 months.
This means that ACHC's stock price may go up by +94.76% over the next 12 months.
We can't find any ETFs which contains Acadia Healthcare Company Inc's stock.
As per our most recent records Acadia Healthcare Company Inc has 19,192 Employees.
Acadia Healthcare Company Inc's registered address is 6100 Tower Circle, Franklin, TN, United States, 37067.
You can get more information about it from Acadia Healthcare Company Inc's website at https://www.acadiahealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ACHC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
